Skip to content

Stem Cell Therapy for Autism Limited to Approved Trials

19 September 20261 min read
NATIONAL AFFAIRSStem Cell Therapyfor Autism Limitedto Approved Trials19 September 2026safalsetu.com

Why in the news

The Health Ministry reminded States and UTs that stem cell treatment for autism is permitted only in a clinical-trial setting.

Key facts

  • Condition: Autism Spectrum Disorder (ASD).
  • Direction: therapy only through duly approved clinical trials.
  • Advisory date: 16 September 2026; addressed to States and UTs.
  • It reiterates rules already in force.
  • Background: the Supreme Court’s decision of 30 January 2026 in the case titled Yash Charitable Trust & Ors. v. Union of India & Ors.

Exam angle

  • Issuing authority: Union Health Ministry.
  • Therapy covered: stem cell therapy for ASD.
  • Court case behind the advisory: Yash Charitable Trust v. Union of India.

Test yourself

1. Stem cell therapy for autism may be given only through which route, per the Health Ministry?

The advisory limits it to duly approved clinical trials.

2. The Health Ministry's advisory on stem cell therapy for ASD was issued on which date?

The advisory was issued on 16 September 2026.

3. The advisory on stem cell therapy for autism follows a Supreme Court judgment in which case?

It follows the 30 January 2026 judgment in Yash Charitable Trust.